Results 1 to 10 of about 6,360,689 (288)

Recombinant proteins in plants [PDF]

open access: yesBMC Proceedings, 2014
Background Over the last few decades, several studies have shown that plants can be a viable option for producing functional recombinant proteins with a wide range of structural characteristics [1]. In addition, the potential benefit for developing countries is a prominent feature that we have recently addressed [2]. Plant-produced recombinant proteins
E. Rech   +11 more
semanticscholar   +3 more sources

Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development

open access: yesFrontiers in Bioengineering and Biotechnology, 2019
Infectious diseases, along with cancers, are among the main causes of death among humans worldwide. The production of therapeutic proteins for treating diseases at large scale for millions of individuals is one of the essential needs of mankind.
Nagesh K. Tripathi, Ambuj Shrivastava
doaj   +2 more sources

Three Parts of the Plant Genome: On the Way to Success in the Production of Recombinant Proteins [PDF]

open access: yesPlants, 2022
Recombinant proteins are the most important product of current industrial biotechnology. They are indispensable in medicine (for diagnostics and treatment), food and chemical industries, and research.
Sergey M. Rozov   +3 more
doaj   +2 more sources

Producing recombinant proteins in Vibrio natriegens [PDF]

open access: yesMicrobial Cell Factories
The diversity of chemical and structural attributes of proteins makes it inherently difficult to produce a wide range of proteins in a single recombinant protein production system.
Matthew Smith   +26 more
doaj   +2 more sources

Stabilizing additives added during cell lysis aid in the solubilization of recombinant proteins. [PDF]

open access: yesPLoS ONE, 2012
Insoluble recombinant proteins are a major issue for both structural genomics and enzymology research. Greater than 30% of recombinant proteins expressed in Escherichia coli (E. coli) appear to be insoluble.
David J Leibly   +5 more
doaj   +2 more sources

Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity [PDF]

open access: yesIranian Journal of Immunology, 2023
Background: Trastuzumab is a humanized monoclonal antibody that targets site-specifically human epidermal growth factor-2 receptor (HER2) cell surface antigen overexpressed in approximately 20% of human breast carcinomas. Despite its positive therapeutic
Soodabeh Shafiee   +5 more
doaj   +1 more source

Engineering and production of recombinant bovine pancreatic ribonuclease enzyme (RNase A) as a potential therapeutic [PDF]

open access: yesمجله بیوتکنولوژی کشاورزی, 2021
Objective  Immunotoxins are one of the most promising ways in therapeutic fields, specially cancer therapy which have a unique toxin-antibody structure, and kill the cancer cell by passing through the cell membrane and entering the target cell.
Masoume Vakili-Azghandi   +3 more
doaj   +1 more source

HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors

open access: yesFrontiers in Bioengineering and Biotechnology, 2021
Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding.
Evan Tan   +3 more
semanticscholar   +1 more source

Recombinant Protein Stability in Cyanobacteria [PDF]

open access: yesACS Synthetic Biology, 2021
The living cell possesses extraordinary molecular and biochemical mechanisms by which to recognize and efficiently remove foreign, damaged, or denatured proteins. This essential function has been a barrier to the overexpression of recombinant proteins in most expression systems.
Xianan Zhang   +3 more
openaire   +5 more sources

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk

open access: yesCancer Cell International, 2022
As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling pathways, such as nuclear factor-κB (NF-κB), Wnt, and mitogen-activated protein (MAP)/phosphoinositide 3 ...
Khadijeh Barzaman   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy